IRCT20210514051289N1
Completed
Phase 3
Effect of Angiotensin-converting enzyme and ß-blockers on the prognosis of patients with severely isolated brain trauma
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- S06.2X
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 96
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Severe trauma
- •Age greater than or equal to 18 years
- •No previous use of beta\-blockers or Angiotensin\-converting enzyme at home
- •Informed consent of the patient's guardian or legal guardian to admit the patient to the study
Exclusion Criteria
- •Renal artery stenosis
- •Chronic kidney disease
- •History of drug allergy
- •Hyperkalemia
- •High creatinine
- •Bradycardia or heart block
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The Effect of Angiotensin Convetring Enzyme Inhibitor on the Quality of Life of Non Hospitalized Patients With Cancer Cachexia in Shiraz University ClinicsGastric cancer.Malignant neoplasm of stomachIRCT2014050511375N3Shiraz University of Midical Sciences40
Completed
Not Applicable
Effect of Angiotensin Converting Enzyme Inhibition (ACEI) on C-Reactive Protein (CRP) Levels: The Ramipril CRP Randomized Evaluation (4R Trial)Healthy volunteers with elevated levels of C-Reactive proteinCirculatory SystemISRCTN31129526Sanofi-Aventis (Canada)400
Recruiting
Not Applicable
Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-AnalysisThere is a controversial debate regarding how to treat cardiovascular disease in COVID-19 confirmed patients. Ones documented that ACE inhibitor may increase risk of fatal COVID-19 by serving entry site for this virus, on contrary ones documented that ACEi and/or ARB may be beneficial for Acute Lung Injury and cardiovascular protection.JPRN-UMIN000041430Faculty of Medicine, Universitas Airlangga
Not yet recruiting
Not Applicable
Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in cancer patientsCancer PatientsJPRN-UMIN000052284Yokohama City University Graduate School of Medicine
Completed
Not Applicable
Pharmacogenetics of angiotensin converting enzyme and relationships with angiotensin converting enzyme activity in Thai populatioACE inhibitor-induced coughpharmacogeneticsangiotensin converting enzyme activityACETCTR20180718001Faculty of Medicine, Thammasat University100